Thyroid associated orbitopathy
Showing 1 - 25 of >10,000
Thyroid Associated Orbitopathy Trial in Cairo (Methotrexate, Triamcinolone Acetonide)
Completed
- Thyroid Associated Orbitopathy
- Methotrexate
- Triamcinolone Acetonide
-
Cairo, EgyptCairo University
Jul 15, 2022
Clinical Activity of TAO Using Periocular Images Taken by
Completed
- Thyroid Eye Disease
- taking periorbital selfie images using smartphones
-
Seongnam-si, Gyeonggi-do, Korea, Republic ofSeoul National University Bundang Hospital
Feb 15, 2023
Graves Ophthalmopathy, Thyroid Associated Ophthalmopathy, Thyroid Associated Orbitopathy Trial in Malmö (Simvastatin 40mg)
Recruiting
- Graves Ophthalmopathy
- +2 more
- Simvastatin 40mg
-
Malmö, SwedenDpt. of Endocrinology, SUS Malmö
Nov 17, 2021
Thyroid Associated Ophthalmopathy, Hypercholesterolemia Trial in Pisa (Atorvastatin, Methylprednisolone)
Completed
- Thyroid Associated Ophthalmopathy
- Hypercholesterolemia
-
Pisa, ItalyOspedale Cisanello-Endocrinology I and II
Aug 12, 2021
Thyroid Eye Disease, Graves Orbitopathy, Endocrine System Diseases Trial in Canada, United Kingdom, United States (Linsitinib,
Recruiting
- Thyroid Eye Disease
- +11 more
- Linsitinib
- Placebo
-
Beverly Hills, California
- +22 more
Jan 30, 2023
Tocilizumab, Thyroid Associated Ophthalmopathy Trial in Guangzhou (Tocilizumab)
Recruiting
- Tocilizumab
- Thyroid Associated Ophthalmopathy
-
Guangzhou, Guangdong, ChinaZhongshan Ophthalmic Center
Oct 11, 2023
Thyroid Eye Disease, Graves' Orbitopathy Trial in Germany, Italy, United States (Teprotumumab, Placebo)
Completed
- Thyroid Eye Disease
- Graves' Orbitopathy
- Teprotumumab
- Placebo
-
Beverly Hills, California
- +13 more
Jan 31, 2022
Thyroid-Associated Ophthalmopathy Trial (Sirolimus 1 mg Oral Tablet, Methylprednisolone)
Not yet recruiting
- Thyroid-Associated Ophthalmopathy
- Sirolimus 1 mg Oral Tablet
- Methylprednisolone
- (no location specified)
Mar 18, 2022
Graves Ophthalmopathy, Graves Disease, Thyroid-associated Ophthalmopathy Trial in Guangzhou (Doxycycline hyclate, Placebo)
Recruiting
- Graves Ophthalmopathy
- +8 more
- Doxycycline hyclate
- Placebo
-
Guangzhou, Guangdong, ChinaZhongshan Ophthalmic Center
Nov 16, 2021
Associated With Mental Fatigue in Graves' Disease
Recruiting
- Graves Disease
- +4 more
-
Gothenburg, SwedenDepartment of Endocrinology, Sahlgrenska University Hospital
Jan 4, 2023
Thyroid Associated Ophthalmopathy Trial (Orbital radiotherapy, Methylprednisolone)
Not yet recruiting
- Thyroid Associated Ophthalmopathy
- Orbital radiotherapy
- Methylprednisolone
- (no location specified)
Mar 24, 2020
Thyroid Eye Disease, Graves Orbitopathy Trial in Germany (Secukinumab, Placebo)
Recruiting
- Thyroid Eye Disease
- Graves Orbitopathy
- Secukinumab
- Placebo
-
Essen, Germany
- +6 more
Jul 14, 2022
Normal Tension Glaucoma, Primary Open-angle Glaucoma, Glaucoma, Suspect Trial in Seongnam-si, Seoul (Eybelis ophthalmic solution
Recruiting
- Normal Tension Glaucoma
- +3 more
- Eybelis ophthalmic solution 0.002%
-
Seongnam-si, Korea, Republic of
- +7 more
Mar 6, 2022
Thyroid Associated Ophthalmopathy, Surgical Procedure, Unspecified Trial in Manresa (3D printing model/guide., Standard surgery)
Recruiting
- Thyroid Associated Ophthalmopathy
- Surgical Procedure, Unspecified
- 3D printing model/guide.
- Standard surgery
-
Manresa, Barcelona, SpainEduard Pedemonte Sarrias
Mar 8, 2022
Thyroid Associated Ophthalmopathies Trial (Sodium selenate, Sugar pill)
Withdrawn
- Thyroid Associated Ophthalmopathies
- Sodium selenate
- Sugar pill
- (no location specified)
Aug 12, 2021
Thyroid Associated Ophthalmopathy Trial in Guangzhou (combination of orbital compression surgery and strabismus surgery, orbital
Not yet recruiting
- Thyroid Associated Ophthalmopathy
- combination of orbital compression surgery and strabismus surgery
- orbital compression
-
Guangzhou, Guangdong, ChinaZhongshan Ophthalmic Center, Sun Yat-sen University
Jun 6, 2021
Thyroid Associated Ophthalmopathy Trial in Guangzhou (Doxycycline Hyclate)
Recruiting
- Thyroid Associated Ophthalmopathy
- Doxycycline Hyclate
-
Guangzhou, Guangdong, ChinaZhongshan Ophthalmic Center
Nov 7, 2021
Thyroid Associated Ophthalmopathy Trial in Guangzhou (immunosuppressive agent)
Recruiting
- Thyroid Associated Ophthalmopathy
- immunosuppressive agent
-
Guangzhou, Guangdong, ChinaZhongshan Ophthalmic Center
Nov 7, 2021
Pheochromocytoma, Paraganglioma, Inherited Cancer Syndrome Trial in San Antonio (Genetic screening)
Recruiting
- Pheochromocytoma
- +7 more
- Genetic screening
-
San Antonio, TexasUniversity of Texas Health Science Center
Aug 25, 2022
Chronic Health Conditions in Down Syndrome-Associated Acute
Not yet recruiting
- Down Syndrome
- +7 more
- Neurological Assessments
- +3 more
- (no location specified)
Jan 18, 2023
Thyroid Eye Disease Trial in Germany, Italy, United States (Teprotumumab)
Completed
- Thyroid Eye Disease
- Teprotumumab
-
Beverly Hills, California
- +12 more
Dec 9, 2021
Thyroid Eye Disease Trial (VRDN-001 10 mg/kg Drug:)
Not yet recruiting
- Thyroid Eye Disease
- VRDN-001 10 mg/kg Drug:
- (no location specified)
Sep 7, 2023
Graves Ophthalmopathy Trial in Italy (Tocilizumab 20 Mg/mL Intravenous Solution, MethylPREDNISolone Injectable Solution)
Recruiting
- Graves Ophthalmopathy
- Tocilizumab 20 Mg/mL Intravenous Solution
- MethylPREDNISolone Injectable Solution
-
Milano, MI, Italy
- +3 more
Aug 3, 2022
Retinal Diseases Trial in Brussels (MRI perfusion imaging using ASL's non-invasive technique)
Recruiting
- Retinal Diseases
- MRI perfusion imaging using ASL's non-invasive technique
-
Brussels, BelgiumCliniques Universitaires Saint Luc
Feb 1, 2023